<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00978900</url>
  </required_header>
  <id_info>
    <org_study_id>EKBB 69/04</org_study_id>
    <nct_id>NCT00978900</nct_id>
  </id_info>
  <brief_title>Effects of Artificial Sweetener on Gastrointestinal (GI) Peptide Secretion</brief_title>
  <official_title>Carbohydrates and Non Caloric Sweeteners: Differential Effects on Appetite and Secretion of Gastrointestinal Satiety Peptide</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the influence of artificial sweeteners (aspartame,
      acesulfame K, sucralose) and carbohydrate sugars (glucose, fructose) on the release of
      gastrointestinal satiety hormones in humans.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Artificial Sweeteners significantly lower energy density of foods and beverages. They are
      used by diabetics as sugar substitutes as well as by consumers as aids for dietary control.
      Despite numerous studies which show mainly no influence of artificial sweeteners on glucose
      metabolism and food intake, discrepancies consist about the real effects of artificial
      sweeteners. Studies by Blundell and Hill in 1986 have however shown that the consumption of
      artificial sweeteners resulted in an increase of appetite ratings; the efficiency of AS has
      therefore been questioned. With respect to the world wide increase in the prevalence in
      obesity, it seems important to clarify whether artificial sweeteners can help regulate body
      weight or not. This study will explore the effect of artificial sweeteners on the release of
      the gastrointestinal satiety hormones PYY, GLP-1, GIP and ghrelin.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">July 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gastrointestinal peptide secretion</measure>
    <time_frame>2 hour blood sampling</time_frame>
  </primary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Acesulfame K</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sucralose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Aspartame</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Glucose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Fructose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Water</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Artificial sweeteners; Carbohydrate Sugars</intervention_name>
    <description>sweetening agent dissolved in tap water, administered via intragastric tube</description>
    <arm_group_label>Acesulfame K</arm_group_label>
    <arm_group_label>Sucralose</arm_group_label>
    <arm_group_label>Aspartame</arm_group_label>
    <arm_group_label>Glucose</arm_group_label>
    <arm_group_label>Fructose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Water</intervention_name>
    <arm_group_label>Water</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy subject with a body-mass index of 19.0-24.5

          -  Normal eating habits

          -  Age 18-40 years

          -  Stable body weight for at least three months

        Exclusion Criteria:

          -  Smoking

          -  Substance abuse

          -  Regular intake of medications (except for oral contraceptives)

          -  Medical or psychiatric illness

          -  history of gastrointestinal disorders

          -  food allergies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christoph Beglinger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Research Center, University Hospital Basel</affiliation>
  </overall_official>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 16, 2009</study_first_submitted>
  <study_first_submitted_qc>September 16, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 17, 2009</study_first_posted>
  <last_update_submitted>September 16, 2009</last_update_submitted>
  <last_update_submitted_qc>September 16, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 17, 2009</last_update_posted>
  <responsible_party>
    <name_title>Beglinger Christoph, Prof. Dr. med.</name_title>
    <organization>Department of Gastroenterology, University Hospital, Basel, Switzerland</organization>
  </responsible_party>
  <keyword>satiety peptides</keyword>
  <keyword>GLP-1</keyword>
  <keyword>PYY</keyword>
  <keyword>ghrelin</keyword>
  <keyword>appetite profile</keyword>
  <keyword>Sweetening Agents</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

